Document is current
Any future updates will be listed below
-
Authors
Kohlhase, Konstantin https://orcid.org/0000-0002-1088-9558
Bohmann, Ferdinand O.
Grefkes, Christian
Strzelczyk, Adam
Willems, Laurent M.
-
Funding
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 4 November 2024
First Online: 2 January 2025
Declarations
:
: The study has been approved by the local ethics committee (2024-1656). Due to the retrospective analysis, written informed consent was waived.
: A. Strzelczyk reports personal fees and grants from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Jazz Pharmaceuticals, Takeda, UCB Pharma, and UNEEG Medical.K. Kohlhase received a research grand from Merck Healthcare Germany GmbH. F.O. Bohmann reports speakers Honoraria from Laerdal, AstraZeneca, Bristol-Myers-Squibb, Pfizer, Medtronic and reports grants and personal fees from Alexion, AstraZeneca, Stryker Neurovascular, Boehringer Ingelheim. L. M. Willems, and C. Grefkes report no competing interests.
